Baird Maintains Outperform on Teradyne, Raises Price Target to $332

Baird analyst Richard Eastman has maintained an 'Outperform' rating on Teradyne (NASDAQ: TER) and raised the price target from $305 to $332. This adjustment reflects a positive outlook on the company's performance.